Articles for author: Russ Cohen

Russ Cohen

Boostaro: Best ED Supplement? Boostaro's Miracle Shake Redefines the 15-Second Blood-Flow Fix Approach

AURORA, Colo., March 29, 2025 (GLOBE NEWSWIRE) — Boostaro is an all-natural dietary supplement designed to combat erectile dysfunction and improve male vitality without the risks of pharmaceuticals. Developed by Tom Bradford, a veteran health researcher and former Department of Health and Human Services (HHS) expert, Boostaro was born from an intensive three-year research quest ...

Russ Cohen

Noteworthy ETF Inflows: QLD, AAPL, NVDA, MSFT

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra QQQ (Symbol: QLD) where we have detected an approximate $253.5 million dollar inflow — that’s a 3.8% increase week over week in outstanding units (from 70,150,000 to 72,850,000). Among the largest underlying components ...

Russ Cohen

U.S. Firms Embrace GenAI to Migrate, Update Mainframes

GenAI features of mainframe services reduce cost, development time in application modernization and cloud migration, ISG Provider Lens™ report says U.S. enterprises are adopting GenAI-based services both to migrate mainframe workloads to the cloud and to keep their legacy systems productive, according to a new research report published today by Information Services Group (ISG) III, ...

Russ Cohen

Should Investors Buy, Sell or Hold PDD Stock Post Q4 Earnings Results?

PDD Holdings PDD recently released its fourth-quarter and fiscal 2024 financial results, showing a mixed performance that has left investors questioning its near-term trajectory. The China-based e-commerce giant reported fourth-quarter revenues of $15.15 billion, representing a 24% year-over-year increase, while missing analyst expectations by approximately $746 million. Despite the revenue miss, earnings per share came ...